BioAmber, which converts renewable feedstocks into bio-succinic acid and other chemicals, filed on Monday with the SEC to raise up to $150 million in an initial public offering. The Montreal, Canada-based company, which was founded in 2008, plans to list on the under the symbol BIOA. Goldman, Sachs & Co., Credit Suisse, and Barclays Capital are the lead underwriters on the deal. No pricing terms were disclosed.
